Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
7680699740017
CH-69974
Konzentrat
Associated product:
Tremfya 200 mg/20 ml, Konzentrat zur Herstellung einer Infusionslösung
google
Article details
- Package size
- 1
- Selling units
- 1
- Measure
- Durchstechflasche(n)
- Galenic form
- Konzentrat
- Galenic group
- Tinkturen/Desinfektion
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
200.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
0.05 MG | Substance | HBESI |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 4163.95
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/11/2025
Authorization holder
Janssen-Cilag AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 69974
- Drug name
- Tremfya, Konzentrat zur Herstellung einer Infusionslösung
- Galenic form
- KOINF
- ATC Code
- L04AC16
- Authorization status
- Z
- Dispensing category
- B
- First authorization
- 10/06/2025
- Authorization expiration date
- 09/06/2030
- IT Number
- 07.15.0.
- Domain
- Human medicine
Package details
- Description (FR)
- TREMFYA 200 mg/20 ml conc perf 200 mg 1 pce
- Description (DE)
- TREMFYA 200 mg/20 ml Konz Inf 200 mg 1 Stk
- Market launch
- 29/07/2025
- Narcotic (BTM)
- No